MetadataShow full item record
AbstractHeat-shock proteins (HSPs) are molecular chaperones that regulate protein folding to ensure correct conformation and translocation and to avoid protein aggregation. Heat-shock proteins are increased in many solid tumours and haematological malignancies. Many oncogenic proteins responsible for the transformation of cells to cancerous forms are client proteins of HSP90. Targeting HSP90 with chemical inhibitors would degrade these oncogenic proteins, and thus serve as useful anticancer agents. This review provides an overview of the HSP chaperone machinery and the structure and function of HSP90. We also highlight the key oncogenic proteins that are regulated by HSP90 and describe how inhibition of HSP90 could alter the activity of multiple signalling proteins, receptors and transcriptional factors implicated in carcinogenesis.
CitationBr J Cancer. 2009 May 19; 100(10):1523-1529
- Heat Shock Protein 90 Inhibition in Cancer Drug Discovery: From Chemistry to Futural Clinical Applications.
- Authors: Özgür A, Tutar Y
- Issue date: 2016
- Heat shock protein 90 inhibitors as therapeutic agents.
- Authors: Gomez-Monterrey I, Sala M, Musella S, Campiglia P
- Issue date: 2012 Sep
- Targeting chaperones in transformed systems--a focus on Hsp90 and cancer.
- Authors: Chiosis G
- Issue date: 2006 Feb
- The therapeutic target Hsp90 and cancer hallmarks.
- Authors: Miyata Y, Nakamoto H, Neckers L
- Issue date: 2013
- Heat shock proteins and cancer: How can nanomedicine be harnessed?
- Authors: Sauvage F, Messaoudi S, Fattal E, Barratt G, Vergnaud-Gauduchon J
- Issue date: 2017 Feb 28